BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36009973)

  • 1. Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant
    Huang C; Chen I; Lin L
    Antibiotics (Basel); 2022 Aug; 11(8):. PubMed ID: 36009973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
    Yi YH; Wang JL; Yin WJ; Xu WH
    Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline.
    Ahmad O; Crawford TN; Myint T
    Infect Dis Ther; 2020 Mar; 9(1):77-87. PubMed ID: 31776844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
    Patel D; Brown ML; Edwards S; Oster RA; Stripling J
    Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Davis KP; McDermott LA; Snydman DR; Aldridge BB
    Microbiol Spectr; 2024 Jun; ():e0097624. PubMed ID: 38916355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftaroline Plus Daptomycin for Refractory Methicillin- Resistant Staphylococcus aureus Bacteremia in a Child.
    Hall AM; McTigue SM
    J Pediatr Pharmacol Ther; 2018; 23(6):490-493. PubMed ID: 30697136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes With Definitive Treatment of Methicillin-Resistant
    Nichols CN; Wardlow LC; Coe KE; Sobhanie MME
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab327. PubMed ID: 34337094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus.
    Hutton MA; Sundaram A; Perri MB; Zervos MJ; Herc ES
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115126. PubMed ID: 32861155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.
    Kalimuddin S; Phillips R; Gandhi M; de Souza NN; Low JG; Archuleta S; Lye D; Tan TT
    Trials; 2014 Jun; 15():233. PubMed ID: 24943129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia.
    Cabanilla MG; Bernauer ML; Briski MJ; Atallah LM; Koury J; Thompson CM; Rodriguez CN; Jakeman B; Byrd TF
    J Pharm Technol; 2024 Jun; 40(3):134-141. PubMed ID: 38784026
    [No Abstract]   [Full Text] [Related]  

  • 14. Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
    Kalil AC; Holubar M; Deresinski S; Chambers HF
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31640977
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
    Holubar M; Meng L; Deresinski S
    Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
    Kale-Pradhan PB; Giuliano C; Jongekrijg A; Rybak MJ
    Pharmacotherapy; 2020 Jul; 40(7):648-658. PubMed ID: 32533859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study.
    Hammond J; Benigno M; Bleibdrey N; Ansari W; Nguyen JL
    Drugs Real World Outcomes; 2024 Jun; 11(2):273-283. PubMed ID: 38564101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
    Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
    Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ; Barber KE; Ireland CE; Rybak MJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
    Wang C; Ye C; Liao L; Wang Z; Hu Y; Deng C; Liu L
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.